NDA[removed]S-002 Page 3 EXJADE® (deferasirox) Tablets for Oral Suspension

First Page		Document Content
Date: 2009-03-31 14:47:09 Organic chemistry Antidotes Chelating agents Deferasirox Triazoles Beta-thalassemia Myelodysplastic syndrome Thalassemia Creatinine Chemistry Medicine Renal physiology		NDA[removed]S-002 Page 3 EXJADE® (deferasirox) Tablets for Oral Suspension Add to Reading List Source URL: www.accessdata.fda.gov Download Document from Source Website File Size: 196,37 KB Share Document on Facebook

	PDF Document DocID: 1xA1h - View Document
	PDF Document DocID: 1wY61 - View Document
	PDF Document DocID: 1w18m - View Document
	RECOGNITIONS ➢ ‘State Award’ given to Thalassemics India in 1998 by Department of Social Welfare, Govt. of NCT of Delhi in recognition of the work done in the field of Thalassemia. ➢ ‘George Englezos Award’ DocID: 1uTi1 - View Document
	A summary of some of the activities of Thalassemics India inJan –Dec) • Services Rendered to Thalassemia patients: Thalassemics India rendered help and support to Thalassemia societies and parents in more than DocID: 1uGOL - View Document